Effect of Gel Renewal During In-office Dental Bleaching
1 other identifier
interventional
33
1 country
1
Brief Summary
Considering the lack of studies related to the violet LED light (405-410nm), applied to tooth whitening, as well as the lack of protocols for its use, this study aims to evaluate if bleaching gel renewal during dental office whitening associated with Violet LED light interferes with final color result and postoperative sensitivity in a randomized, blinded, split-mouth study. Thirty-three volunteers will be selected to participate in the study (n = 33), and the study groups will be: G1 (Permanence of the Whitening Gel on the tooth enamel for 15 minutes) and G2 (3 Whitening Gel renewal every 5 minutes - Total of 15 minutes). In both G1 and G2, teeth will be illuminated with the Violet LED (405-410nm). In the same patient the two treatments (G1 and G2) will be performed, with a split-mouth protocol. The primary outcome will be immediate and mediated color change, quantitatively assessed by colorimetric (color scale) and spectrophotometry tests. Dental sensitivity will also be evaluated during and after tooth whitening using the VAS pain scale. There will be 3 whitening sessions with a 7-day interval between them. The alteration of color and presence of sensitivity will also be evaluated at the times of 14 days and 2 months after the whitening ends. A gel containing 35% hydrogen peroxide will be used. The final color evaluator and responsible for interviewing the patient about the sensitivity will be blind as to which treatment was applied on each side of the patient's arcade.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedFirst Submitted
Initial submission to the registry
June 9, 2019
CompletedFirst Posted
Study publicly available on registry
July 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedJuly 10, 2019
July 1, 2019
11 months
June 9, 2019
July 5, 2019
Conditions
Outcome Measures
Primary Outcomes (6)
Teeth Color 1
assessed quantitatively by colorimetric color scale
Immediately after treatment
Teeth Color 2
assessed quantitatively by spectrophotometry
Immediately after treatment
Teeth Color 1
assessed quantitatively by colorimetric color scale
14 days after treatment
Teeth Color 2
assessed quantitatively by spectrophotometry
14 days after treatment
Teeth Color 1
assessed quantitatively by colorimetric color scale
2 months after treatment
Teeth Color 2
assessed quantitatively by spectrophotometry
2 months after treatment
Secondary Outcomes (3)
Dental sensitivity
Immediately after treatment
Dental sensitivity
14 days after treatment
Dental sensitivity
2 months after treatment
Study Arms (2)
G1 - Permanence of the Whitening Gel
EXPERIMENTALPermanence of the Whitening Gel (Biological Product: 35% Hydrogen Peroxide) on the tooth enamel during the 15 minutes of dental-bleaching
G2 - Renewal of the Whitening Gel
EXPERIMENTAL3 Whitening Gel (Biological Product: 35% Hydrogen Peroxide) renewal every 5 minutes during the 15 minutes of dental-bleaching
Interventions
After gum protection, the bleaching gel (35% hydrogen peroxide) was applied to the surface of the tooth and irradiated with VIOLET LED
Eligibility Criteria
You may qualify if:
- Good oral hygiene conditions
- Good general health conditions and without systemic disease
- Presence of all teeth, without caries, periodontal disease, restorations, endodontic treatment, crowns
- Patients with dental color A3 or darker, according to the VITA \* Classical Color Scale.
You may not qualify if:
- Pregnant and lactating female patients
- Presence of caries, periodontal disease or any other infectious source in the oral cavity
- Systematic use of tobacco and alcoholic beverages
- Chronic use of corticosteroids, as well as who makes use of analgesics or anti-inflammatories before or during 48 hours after dental bleaching
- Patients with dentin hypersensitivity
- Patients with tooth color alteration by tetracycline, fluorosis, endodontic treatment.
- Volunteers who use removable prostheses
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Ibirapuera
São Paulo, São Paulo, 04661-100, Brazil
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor
Study Record Dates
First Submitted
June 9, 2019
First Posted
July 10, 2019
Study Start
March 1, 2019
Primary Completion
February 1, 2020
Study Completion
April 1, 2020
Last Updated
July 10, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share